Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Video: ‘Have you eaten?’ KC Pinoy adds food math to flavorful Filipino fare
Editor’s note: The following content about Chrissy Nucum’s KC Pinoy is sponsored by Mid-Continent Public Library but independently produced by Startland News. KC Pinoy food truck’s last customer of the day was aptly named: Lucky. “We’ve had a good enough day to break a hundred [dollar bill],” owner Chrissy Nucum told the diner at the…
Blue Hills incubator merging with mission-based urban core developer
A catalyst for change within the neighborhoods surrounding Prospect Avenue, the Blue Hills incubator is expected to continue serving entrepreneurs after merging with a leading development group in the urban core. The not-for-profit formed by combining the expertise of Blue Hills Community Services and Swope Community Builders aims to reclaim areas of Kansas City by…
Hungry Sprint Accelerator startups bite into corporate partnerships at Demo Day (Photos)
Winning a mother’s trust is a big deal, said Michael Moran, founder of MoPro, a high-protein, low-sugar Greek yogurt that was among the 2018 Sprint Accelerator cohort’s dairy-centric startups. But what’s perhaps even better than earning Mom’s blessing? Winning financial support from a key backer. Dairy Farmers of America announced a partnership with MoPro Tuesday…
Can KC founders replicate success with WeWork Creator Awards?
After two area founders snagged sizable cash prizes in past contests, a global coworking giant is re-igniting the WeWork Creator Awards competition to recognize entrepreneurs’ work. WeWork plans to dish out at least $238,000 and up to $634,000 in awards to the Eastern United States’ region, which includes Kansas City in this year’s contest parameters. WeWork…